An interventional study of Strength training in Hypogonadism, Male, Physical Activity and Testosterone Deficiency, sponsored by Comenius University. Completed at 1 site in Slovakia. Open to male participants aged 45 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-07-30.
Sponsored by Comenius University · Not applicable, Interventional, and Basic science
This study examines the effect of 12-week strength training program with and without testosterone replacement therapy (TRT) on body composition, physical function, selected biochemical markers of metabolic health, molecular parameters of training adaptation and the quality of life patients with ADAM. The investigators believe, that strength training program performed 2 times per week for 12 weeks can improve body composition (decrease fat mass and gain lean mass), muscle strength, muscle power and general quality of life in all training groups. In addition, combination TRT and strength training could help decrease fat mass, improve BMI, cardio-respiratory fitness and thus provide optimal therapy combination for hypogonadal ageing males.
The study is 3 groups controlled 12-week study to assess the effect of testosterone replacement therapy (TRT) with strength training (ST) and strength training (ST) for hypogonadal participants without testosterone replacement therapy (NON-TRT) with control healthy eugonadal group, that is also engaged in strength training.
Strength training protocol starts one week after all the pre-intervention testing. The intervention is performed at the Comenius University in Bratislava, Faculty of Physical Education and Sport (FSPORT CU) in Slovakia. The strength training protocol follows a modified resistance exercise program. The participants perform strength training sessions two times per week for 12 weeks. All training sessions are supervised and guided by professional coaches with university degree in sports training to ensure safety, technique and progression in training load, with a maximum of three participants per coach.
Each training session include 5-minute general dynamic warm-up followed by progressive strength training with exercises for the entire body. The strength exercises are performed with free weights and on machines. The training program consist of 6 exercises for upper and lower body at an intensity of 60-80% (8 - 12RM: the load that induces technique failure in eight or twelve repetitions) of one-repetition maximum and takes approximately 60 minutes. The participants are instructed to perform concentric action in 2 s and immediately after eccentric action in also 2 s. The exercises performed are: leg press, split squats, bench press, knee extension, knee flexion, seated cable rows, seated cable pull downs, dumbbell bench press, incline dumbbell bench press. Training equipment is provided by KOHI Leopoldov, Slovakia and Technogym, Italia.
Clinical and muscle cellular outcomes are collected before the intervention (pre-testing assessments) and after the intervention (post-testing assessments). Post intervention measurements start 7 days after intervention and go up to 3 weeks after intervention.
Clinical outcomes Body composition analysis is measured by Dual-energy X-ray Absorptiometry using Hologic fan-beam bone densitometer Discovery QDR series. LBM(lean body mass) is measured in total body and separately for arms, legs and trunk. The changes in lower and upper body LBM are investigated separately because of differences in androgen sensitivity in leg muscles compared to neck, chest and shoulder muscles. Body weight is measured by bioimpedance scale, the height by stadiometer and waist circumference by tape. The body mass index is calculated.
Biochemical outcomes Fasting morning venous blood is taken from 8:00 am to 10:00 am. The haematological and biochemical parameters analysed are Haemoglobin, hematocrits, leucocytes, thrombocytes, glucose, urea, sodium, potassium, calcium, ALAT, total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, testosterone, oestrogen, LH, FSH, SHBG, albumin, bilirubin, total protein, CRP, insulin, PSA.
Physical functioning Muscle strength is measured by novel portable isometric knee dynamometer (maximal voluntary contraction of isometric knee extension, isometric knee flexion), hand grip strength dynamometry by Camry Digital Hand Dynamometer, predicted 1RM leg press from multiple repetition maximum testing. Cardio-respiratory fitness is measured by The Single Stage Treadmill Walking Test on Woodway Pro Treadmill, 10-m fast walk and 10-m usual walk measured by Photocells.
Quality of life The general health status is measured by The Short Form (36) Health Survey patient-reported survey of patient health (SF-36). In addition to that clinically investigating the health-related quality of life (HRQoL) and symptoms of aging men are measured by Aging Males' Symptom Scale (AMS).
Muscle cellular outcomes Muscle biopsies are obtain from approximately 80% of the subjects included in the study. Participants not willing to undergo biopsy are still eligible for trial participation.
With the participant in a supine position, a 5 mm Muscle Biopsy Cannula (Bergstrom-stille, Sweden) with manual suction is used to obtain muscle samples (200 mg), under local anaesthesia (Lidocain 2%,). Before the intervention the biopsy is obtained from the mid-section of the right musculus vastus lateralis, and after the intervention the biopsy is obtained 3 cm proximal to the pre-intervention biopsy.
Exclusion Criteria:
Strength training
Procedure: Strength training
Strength training and regular prescribed testosterone therapy given by participant urologist.
Procedure: Strength training
Strength training
Procedure: Strength training
The participants perform strength training sessions two times per week for 12 weeks. Each training session include 5-minute general dynamic warm-up followed by progressive strength training with exercises for the entire body. The strength exercises are performed with free weights and on machines. The training program consist of 6 exercises for upper and lower body at an intensity of 60-80% (8 - 12RM: the load that induces technique failure in eight or twelve repetitions) of one-repetition maximum and takes approximately 60 minutes. The exercises performed are: leg press, split squats, bench press, knee extension, knee flexion, seated cable rows, seated cable pull downs, dumbbell bench press, incline dumbbell bench press.
Change From Baseline in Lean Mass
Total body by Dual-energy X-ray Absorptiometry using Hologic fan-beam bone densitometer Discovery QDR series.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in Fat Mass
Total body by Dual-energy X-ray Absorptiometry using Hologic fan-beam bone densitometer Discovery QDR series.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in Total Body Mass
Total body by Dual-energy X-ray Absorptiometry using Hologic fan-beam bone densitometer Discovery QDR series.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in 10-m Usual Walk Test
Measured in seconds by Microgates Photocells and than calculated to meters per second.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in 10-m Fast Walk Test
Measured in seconds by Microgates Photocells than calculated to meters per second
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in Handgrip Strength
Measured by Camry Digital Hand Dynamometer.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in Maximal Voluntary Contraction (MVC) of Isometric Knee Extension
Measured by Portable Isometric Knee Dynamometer.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in Maximal Voluntary Contraction (MVC) of Isometric Knee Flexion
Measured by Portable Isometric Knee Dynamometer.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in The Single Stage Treadmill Walking Test
This test is focused on calculated VO2max in ml.kg-1.min-1 from speed measured on Woodway Pro Treadmill.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in Predicted One Repetition Maximum on Leg Press
One repetition maximum in kg on leg press is predicted from multiple repetition maximum testing and measured on Life Fitness Signature Series Leg Press machine.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in Maximal Voluntary Contraction in Benchpress
Measured in N by FiTRO Force Plates.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in The Short Form Health Survey (SF-36)
Patient-reported survey of patient health (SF-36), clinically investigating the health-related quality of life (HRQoL). The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. The items contributing to a scale are scored so that a higher score represents better health, and they are averaged together to create the scale score.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in Aging Males' Symptom (AMS) Scale
Measuring symptoms of ageing men by numeric score scale. The questionnaire has for each of the 17 item an option to check one of 5 degrees of severity (severity 1...5 points at the questionnaire). The composite scores for each of the three dimensions (sub-scales) is based on adding up the scores of the items of the respective dimensions. The composite score (total score) is the sum of the three dimension scores. Higher score means higher severity of symptoms. The minimum total score is 17 and the maximum is 85.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in Metabolic Parameters
Fasting morning venous blood was taken after overnight (10-hour) fasting and 15 min rest from cubital vein from 8:00 am to 10:00 am \[69\] into closed system collection tubes containing beads coated with a clotting activator and polyacryl ester-gel (Sarstedt AG \& Co, Germany). The blood will be centrifuged (3000g, 4°C, 10min) immediately after sampling to obtain EDTA plasma or they will be centrifuged (3000g, 4°C, 20min) after 30min at RT, to obtain serum.
Time frame: 7 days before intervention, 7 days after intervention
Change From Baseline in Liver Function Blood Parameters
Fasting morning venous blood was taken after overnight (10-hour) fasting and 15 min rest from cubital vein from 8:00 am to 10:00 am \[69\] into closed system collection tubes containing beads coated with a clotting activator and polyacryl ester-gel (Sarstedt AG \& Co, Germany). The blood will be centrifuged (3000g, 4°C, 10min) immediately after sampling to obtain EDTA plasma or they will be centrifuged (3000g, 4°C, 20min) after 30min at RT, to obtain serum.
Time frame: 7 days before intervention, 14 days after intervention
Change From Baseline in Hormonal Parameters
Fasting morning venous blood was taken after overnight (10-hour) fasting and 15 min rest from cubital vein from 8:00 am to 10:00 am \[69\] into closed system collection tubes containing beads coated with a clotting activator and polyacryl ester-gel (Sarstedt AG \& Co, Germany). The blood will be centrifuged (3000g, 4°C, 10min) immediately after sampling to obtain EDTA plasma or they will be centrifuged (3000g, 4°C, 20min) after 30min at RT, to obtain serum.
Time frame: 7 days before intervention, 14 days after intervention
Change From Baseline in Ions
Fasting morning venous blood was taken after overnight (10-hour) fasting and 15 min rest from cubital vein from 8:00 am to 10:00 am \[69\] into closed system collection tubes containing beads coated with a clotting activator and polyacryl ester-gel (Sarstedt AG \& Co, Germany). The blood will be centrifuged (3000g, 4°C, 10min) immediately after sampling to obtain EDTA plasma or they will be centrifuged (3000g, 4°C, 20min) after 30min at RT, to obtain serum.
Time frame: 7 days before intervention, 14 days after intervention
Change From Baseline in CRP
Fasting morning venous blood was taken after overnight (10-hour) fasting and 15 min rest from cubital vein from 8:00 am to 10:00 am \[69\] into closed system collection tubes containing beads coated with a clotting activator and polyacryl ester-gel (Sarstedt AG \& Co, Germany). The blood will be centrifuged (3000g, 4°C, 10min) immediately after sampling to obtain EDTA plasma or they will be centrifuged (3000g, 4°C, 20min) after 30min at RT, to obtain serum.
Time frame: 7 days before intervention, 14 days after intervention
Change From Baseline in Muscle Fiber Size
Muscle fiber size measured in um2. Analysis of the date are in progress.
Time frame: 7 days before intervention, 14 days after intervention
Change From Baseline in Regulators of Muscle Fiber Size
Regulators of muscle fiber size - number of myonuclei per muscle fiber, number of satellite cells per muscle fiber, number of satellite cells and myonuclei positive for androgen receptors, proteins involved in muscle hypertrophy. Analysis of the date are in progress.
Time frame: 7 days before intervention, 14 days after intervention
| Milestone | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Started | 6 | 8 | 8 |
| Completed | 6 | 8 | 8 |
| Not completed | 0 | 0 | 0 |
Total body by Dual-energy X-ray Absorptiometry using Hologic fan-beam bone densitometer Discovery QDR series.
| grams | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in Lean Mass | 2734 ± 1967 | 499 ± 1566 | 2268 ± 2609 |
Total body by Dual-energy X-ray Absorptiometry using Hologic fan-beam bone densitometer Discovery QDR series.
| grams | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in Fat Mass | -1969 ± 2526 | -1263 ± 1920 | -755 ± 1514 |
Total body by Dual-energy X-ray Absorptiometry using Hologic fan-beam bone densitometer Discovery QDR series.
| grams | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in Total Body Mass | 621.53 ± 2922.45 | -821.73 ± 3279.29 | 1435.04 ± 3655.01 |
Measured in seconds by Microgates Photocells and than calculated to meters per second.
| m/s | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in 10-m Usual Walk Test | 0 ± 0.089 | -0.06 ± 0.146 | -0.05 ± 0.136 |
Measured in seconds by Microgates Photocells than calculated to meters per second
| m/s | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in 10-m Fast Walk Test | 0.05 ± 0.255 | -0.1 ± 0.172 | -0.13 ± 0.253 |
Measured by Camry Digital Hand Dynamometer.
| kg | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in Handgrip Strength | -1.41 ± 4.00 | 0.84 ± 2.12 | -0.02 ± 3.28 |
Measured by Portable Isometric Knee Dynamometer.
| Nm | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in Maximal Voluntary Contraction (MVC) of Isometric Knee Extension | -9.65 ± 93.44 | 8.15 ± 28.97 | 1.35 ± 69.50 |
Measured by Portable Isometric Knee Dynamometer.
| Nm | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in Maximal Voluntary Contraction (MVC) of Isometric Knee Flexion | 2.32 ± 27.89 | 24.64 ± 36.09 | 14.36 ± 28.13 |
This test is focused on calculated VO2max in ml.kg-1.min-1 from speed measured on Woodway Pro Treadmill.
| ml.kg-1.min-1 | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in The Single Stage Treadmill Walking Test | 0.61 ± 0.64 | 0.25 ± 0.64 | 0.42 ± 0.54 |
One repetition maximum in kg on leg press is predicted from multiple repetition maximum testing and measured on Life Fitness Signature Series Leg Press machine.
| kg | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in Predicted One Repetition Maximum on Leg Press | 45.31 ± 28.39 | 51.59 ± 34.43 | 51.40 ± 27.16 |
Measured in N by FiTRO Force Plates.
| N | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in Maximal Voluntary Contraction in Benchpress | -6.49 ± 147.12 | 64.31 ± 143.29 | 66.68 ± 103.38 |
Patient-reported survey of patient health (SF-36), clinically investigating the health-related quality of life (HRQoL). The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. The items contributing to a scale are scored so that a higher score represents better health, and they are averaged together to create the scale score.
| score on a scale | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in The Short Form Health Survey (SF-36) | 2.50 ± 9.87 | 7.50 ± 18.52 | 3.75 ± 12.46 |
Measuring symptoms of ageing men by numeric score scale. The questionnaire has for each of the 17 item an option to check one of 5 degrees of severity (severity 1...5 points at the questionnaire). The composite scores for each of the three dimensions (sub-scales) is based on adding up the scores of the items of the respective dimensions. The composite score (total score) is the sum of the three dimension scores. Higher score means higher severity of symptoms. The minimum total score is 17 and the maximum is 85.
| score on a scale | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in Aging Males' Symptom (AMS) Scale | -4.83 ± 7.41 | -2.00 ± 5.98 | -6.25 ± 5.09 |
Fasting morning venous blood was taken after overnight (10-hour) fasting and 15 min rest from cubital vein from 8:00 am to 10:00 am \[69\] into closed system collection tubes containing beads coated with a clotting activator and polyacryl ester-gel (Sarstedt AG \& Co, Germany). The blood will be centrifuged (3000g, 4°C, 10min) immediately after sampling to obtain EDTA plasma or they will be centrifuged (3000g, 4°C, 20min) after 30min at RT, to obtain serum.
| mmol/l | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| S-Bilirubin | 0.0006 ± 0.0038 | 0.0008 ± 0.004 | -0.003 ± 0.006 |
| S-Creatinine | -0.006 ± 0.008 | -0.0002 ± 0.0052 | 0.0011 ± 0.0038 |
| S-Glucose | 0.33 ± 0.44 | 0.29 ± 0.50 | -0.02 ± 0.65 |
| S-Total Cholesterol | 0.10 ± 0.67 | 0.22 ± 0.71 | 0.29 ± 1.11 |
| S-HDL Cholesterol | 0.06 ± 0.10 | 0.09 ± 0.17 | 0.08 ± 0.20 |
| S-LDL Cholesterol | -0.06 ± 0.52 | -0.30 ± 1.07 | -0.12 ± 0.84 |
| S-Triglyceride | -0.20 ± 0.46 | 0.38 ± 1.27 | 0.28 ± 0.86 |
| S-Urea | -0.16 ± 1.45 | 3.77 ± 8.58 | 0.84 ± 1.26 |
| S-Uric Acid | -0.016 ± 0.071 | 0.004 ± 0.047 | -0.010 ± 0.053 |
Fasting morning venous blood was taken after overnight (10-hour) fasting and 15 min rest from cubital vein from 8:00 am to 10:00 am \[69\] into closed system collection tubes containing beads coated with a clotting activator and polyacryl ester-gel (Sarstedt AG \& Co, Germany). The blood will be centrifuged (3000g, 4°C, 10min) immediately after sampling to obtain EDTA plasma or they will be centrifuged (3000g, 4°C, 20min) after 30min at RT, to obtain serum.
| µkat/l | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| S-ALP | 0.06 ± 0.11 | 0.05 ± 0.11 | 0.10 ± 0.18 |
| S-ALT | 0.19 ± 0.49 | -0.05 ± 0.28 | -0.07 ± 0.10 |
| S-AMS | 0.06 ± 0.23 | 0.05 ± 0.08 | 0.07 ± 0.16 |
| S-AST | 0.05 ± 0.19 | 0.00 ± 0.19 | -0.01 ± 0.04 |
| S-GMT | -0.13 ± 0.23 | 0.01 ± 0.16 | -0.05 ± 0.27 |
Fasting morning venous blood was taken after overnight (10-hour) fasting and 15 min rest from cubital vein from 8:00 am to 10:00 am \[69\] into closed system collection tubes containing beads coated with a clotting activator and polyacryl ester-gel (Sarstedt AG \& Co, Germany). The blood will be centrifuged (3000g, 4°C, 10min) immediately after sampling to obtain EDTA plasma or they will be centrifuged (3000g, 4°C, 20min) after 30min at RT, to obtain serum.
| nmol/l | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| S-Testosterone | 1.69 ± 1.20 | -0.50 ± 3.51 | -1.99 ± 2.59 |
| S-SHBG | 2.42 ± 4.67 | -1.35 ± 6.10 | -2.93 ± 6.55 |
| S-Cortisol | -32.93 ± 103.28 | -44.60 ± 140.83 | 34.34 ± 159.29 |
| S-Insuline | 0.004 ± 0.046 | 0.019 ± 0.061 | 0.006 ± 0.023 |
Fasting morning venous blood was taken after overnight (10-hour) fasting and 15 min rest from cubital vein from 8:00 am to 10:00 am \[69\] into closed system collection tubes containing beads coated with a clotting activator and polyacryl ester-gel (Sarstedt AG \& Co, Germany). The blood will be centrifuged (3000g, 4°C, 10min) immediately after sampling to obtain EDTA plasma or they will be centrifuged (3000g, 4°C, 20min) after 30min at RT, to obtain serum.
| mmol/l | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| S-Chlorides | -1.47 ± 2.50 | -0.77 ± 4.21 | -0.33 ± 3.78 |
| S-Potassium | 0.17 ± 0.34 | 0.06 ± 0.13 | 0.14 ± 0.31 |
| S-Sodium | 0.08 ± 1.26 | -0.15 ± 1.31 | -0.19 ± 1.13 |
Fasting morning venous blood was taken after overnight (10-hour) fasting and 15 min rest from cubital vein from 8:00 am to 10:00 am \[69\] into closed system collection tubes containing beads coated with a clotting activator and polyacryl ester-gel (Sarstedt AG \& Co, Germany). The blood will be centrifuged (3000g, 4°C, 10min) immediately after sampling to obtain EDTA plasma or they will be centrifuged (3000g, 4°C, 20min) after 30min at RT, to obtain serum.
| mg/l | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males |
|---|---|---|---|
| Change From Baseline in CRP | 0.02 ± 9.40 | 0.13 ± 2.26 | -1.67 ± 2.40 |
Muscle fiber size measured in um2. Analysis of the date are in progress.
Results for this outcome have not been posted.
Regulators of muscle fiber size - number of myonuclei per muscle fiber, number of satellite cells per muscle fiber, number of satellite cells and myonuclei positive for androgen receptors, proteins involved in muscle hypertrophy. Analysis of the date are in progress.
Results for this outcome have not been posted.
Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Hypogonadal Males Without TRT | 0/6 (0%) | 0/6 (0%) | 0/6 (0%) |
| Hypogonadal Males With TRT | 0/8 (0%) | 0/8 (0%) | 0/8 (0%) |
| Healthy Eugonadal Males | 0/8 (0%) | 0/8 (0%) | 0/8 (0%) |
| Age, Continuous(years) | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males | Total |
|---|---|---|---|---|
| Mean | 48.41 ± 7.9 | 43.03 ± 2.9 | 50.11 ± 5.1 | 47.07 ± 7.15 |
| Sex: Female, Male(Participants) | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males | Total |
|---|---|---|---|---|
| Female | 0 | 0 | 0 | 0 |
| Male | 6 | 8 | 8 | 22 |
| Race/Ethnicity, Customized(participants) | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males | Total |
|---|---|---|---|---|
| Slovak | 6 | 8 | 8 | 22 |
| Region of Enrollment(participants) | Hypogonadal Males Without TRT | Hypogonadal Males With TRT | Healthy Eugonadal Males | Total |
|---|---|---|---|---|
| Slovakia | 6 | 8 | 8 | 22 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: Undecided
This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Comenius University